“Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment”
This five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.
Drug - Buprenorphine/Naloxone
Participants will begin buprenorphine pharmacotherapy using the MedicaSafe buprenorphine dispensing device immediately after an on-site intake at a community supervision office and continue such treatment until they are transitioned to community buprenorphine treatment
Treatment as usual
Participants will receive a referral to buprenorphine treatment in the community
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment